Status:
UNKNOWN
The Impact of Reducing Overtreatment on Quality of Life in Children With Refractory Epilepsy
Lead Sponsor:
Institute of Child Health
Conditions:
Intractable Epilepsy
Eligibility:
All Genders
6-21 years
Phase:
PHASE4
Brief Summary
The primary aim of the study is to determine the effect of reducing the number and/or dose of anti epileptic drugs on an individual's quality of life and seizure control in people with difficult to co...
Eligibility Criteria
Inclusion
- Young people aged 6-21 years with intractable epilepsy receiving antiepileptic drug polytherapy
Exclusion
- None
Key Trial Info
Start Date :
September 1 2008
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
64 Patients enrolled
Trial Details
Trial ID
NCT00647322
Start Date
September 1 2008
Last Update
March 31 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Neurosciences Unit, UCL Institute of Child Health, The Wolfson Centre,
London, United Kingdom, WC1N 1EH